{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T02:02:40Z","timestamp":1784426560607,"version":"3.55.0"},"reference-count":61,"publisher":"American Association for Laboratory Animal Science","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:p>Orthotopic tumor models are critical to the development of new cancer therapies, as they have the greatest potential to mimic human cancer progression. However, such models are often underutilized due to practical challenges. These challenges include the need for specialized surgeries and the presence of complicating symptoms, such as ascites fluid accumulation in ovarian cancer and liver disease models, as well as ulceration of breast tumors growing in the mammary fat pad. An adaptable, quantitative animal health assessment system that employs simple, noninvasive visual measurements can enable researchers to realize the full potential of these models while safeguarding humane endpoints. The goal of this work was to establish health-scoring systems for translationally relevant ovarian (ID8-Defb29\/Vegf-A) and breast cancer (triple-negative 4T1) models. We developed a tractable health assessment system by monitoring a combination of activity and responsiveness, hair coat condition, respiratory function, changes in body weight, posture, gait, tumor size (where measurable), and extent of ulceration, and scoring each parameter on a simple numerical scale. The scores at which euthanasia or other interventions were required were estimated and then adjusted based on clinical assessment by a team of researchers and veterinarians. These semiquantitative health-scoring systems were applied to survival experiments, in which mice were euthanized at a predetermined score or upon meeting a superseding health criterion, to confirm their applicability and effectiveness in maintaining humane endpoints. The scoring systems presented are intended to build on previously established generic tumor model scoring systems that do not account for the particular phenotypes present in orthotopic breast and ovarian cancer models.<\/jats:p>","DOI":"10.30802\/aalas-jaalas-26-027","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T01:42:23Z","timestamp":1784425343000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["Robust Scoring System to Evaluate Animal Well-Being in Murine (Mus musculus) Orthotopic Breast Cancer and Ovarian Cancer Models"],"prefix":"10.30802","author":[{"given":"Ranya","family":"Al-Khaledy","sequence":"first","affiliation":[{"name":"Department of Chemical Engineering, University of Texas at Austin, Austin, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, University of Texas at Austin, Austin, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Shukla","sequence":"additional","affiliation":[{"name":"Animal Resources Center, University of Texas, Austin, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladan","family":"Mashouri","sequence":"additional","affiliation":[{"name":"Department of Molecular Biosciences, University of Texas, Austin, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everett","family":"Stone","sequence":"additional","affiliation":[{"name":"Department of Molecular Biosciences, University of Texas, Austin, Texas; and"},{"name":"Department of Oncology, University of Texas Dell Medical School, LiveSTRONG Cancer Institutes, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Badeaux","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, University of Texas at Austin, Austin, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"12258","reference":[{"issue":"6","key":"bib1","series-title":"Animals (Basel).","first-page":"846","article-title":"Animal research regulation: improving decision-making and adopting a transparent system to address concerns around approval rate of experiments","volume":"14","author":"Azilagbetor DM","year":"2024","unstructured":"Azilagbetor DM, Shaw D, Elger BS. Animal research regulation: improving decision-making and adopting a transparent system to address concerns around approval rate of experiments. Animals (Basel). 2024;14(6):846."},{"issue":"1","key":"bib2","series-title":"ILAR J.","first-page":"50","article-title":"Everything you need to know about satisfying IACUC protocol requirements","volume":"60","author":"Mohan S","year":"2019","unstructured":"Mohan S, Foley PL. Everything you need to know about satisfying IACUC protocol requirements. ILAR J. 2019;60(1):50\u201357."},{"issue":"2","key":"bib3","series-title":"Ethics Behav.","first-page":"163","article-title":"Ethical decision making about animal experiments","volume":"7","author":"Orlans FB","year":"1997","unstructured":"Orlans FB. Ethical decision making about animal experiments. Ethics Behav. 1997;7(2):163\u2013171."},{"issue":"4","key":"bib4","series-title":"Dis Model Mech.","first-page":"359","article-title":"In vivo models in breast cancer research: progress, challenges and future directions","volume":"10","author":"Holen I","year":"2017","unstructured":"Holen I, Speirs V, Morrissey B, Blyth K. In vivo models in breast cancer research: progress, challenges and future directions. Dis Model Mech. 2017;10(4):359\u2013371."},{"key":"bib5","series-title":"Principles of Animal Research for Graduate and Undergraduate Students.","first-page":"117","article-title":"Bioethics and animal research","author":"Hickman DL","year":"2016","unstructured":"Hickman DL, Johnson J, Vemulapalli TH, Crisler JR, Shepherd R. Bioethics and animal research. In: Suckow MA, Stewart K. eds. Principles of Animal Research for Graduate and Undergraduate Students. Elsevier; 2016:117\u2013175."},{"issue":"11","key":"bib6","series-title":"Cancer Discov.","first-page":"1358","article-title":"Mouse models for cancer immunotherapy research","volume":"8","author":"Olson B","year":"2018","unstructured":"Olson B, Li Y, Lin Y, Liu ET, Patnaik A. Mouse models for cancer immunotherapy research. Cancer Discov. 2018;8(11):1358\u20131365."},{"issue":"9","key":"bib7","series-title":"Nat Protoc.","first-page":"2571","article-title":"OBSERVE: guidelines for the refinement of rodent cancer models","volume":"19","author":"De Vleeschauwer SI","year":"2024","unstructured":"De Vleeschauwer SI, van de Ven M, Oudin A, et al. OBSERVE: guidelines for the refinement of rodent cancer models. Nat Protoc. 2024;19(9):2571\u20132596."},{"issue":"1","key":"bib8","series-title":"Cell Death Discov.","first-page":"222","article-title":"Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments","volume":"11","author":"Wang Q","year":"2025","unstructured":"Wang Q, Yuan F, Zuo X, Li M. Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments. Cell Death Discov. 2025;11(1):222."},{"key":"bib9","series-title":"Curr Protoc Mouse Biol.","first-page":"145","article-title":"Health evaluation of experimental laboratory mice","volume":"2","author":"Burkholder T","year":"2012","unstructured":"Burkholder T, Foltz C, Karlsson E, Linton CG, Smith JM. Health evaluation of experimental laboratory mice. Curr Protoc Mouse Biol. 2012;2:145\u2013165."},{"key":"bib10","series-title":"Lab Animal.","first-page":"28","article-title":"Guidelines for assessing the health and condition of mice","volume":"28","author":"Foltz CJ","year":"1999","unstructured":"Foltz CJ, Ullman-Cullere M. Guidelines for assessing the health and condition of mice. Lab Animal. 1999;28:28\u201332."},{"key":"bib11","year":"2021","unstructured":"The University of Queensland Research Support. Standard score sheet for the assessment of wellbeing in mice: tumours. The University of Queensland; 2021. https:\/\/research-support.uq.edu.au\/resources-and-support\/ethics-integrity-and-compliance\/animal-ethics\/monitoring-animals."},{"issue":"6","key":"bib12","series-title":"Comp Med.","first-page":"520","article-title":"A review of the effects of pain and analgesia on immune system function and inflammation: relevance for preclinical studies","volume":"69","author":"DeMarco GJ","year":"2019","unstructured":"DeMarco GJ, Nunamaker EA. A review of the effects of pain and analgesia on immune system function and inflammation: relevance for preclinical studies. Comp Med. 2019;69(6):520\u2013534."},{"issue":"6","key":"bib13","series-title":"Comp Med.","first-page":"501","article-title":"Influence of pain and analgesia on cancer research studies","volume":"69","author":"Taylor DK","year":"2019","unstructured":"Taylor DK. Influence of pain and analgesia on cancer research studies. Comp Med. 2019;69(6):501\u2013509."},{"issue":"14","key":"bib14","series-title":"Br J Pharmacol.","first-page":"2726","article-title":"Influence of opioids on immune function in patients with cancer pain: from bench to bedside","volume":"175","author":"Boland JW","year":"2018","unstructured":"Boland JW, Pockley AG. Influence of opioids on immune function in patients with cancer pain: from bench to bedside. Br J Pharmacol. 2018;175(14):2726\u20132736."},{"issue":"3","key":"bib15","series-title":"Clin Transl Sci.","first-page":"e70180","article-title":"Buprenorphine\u2019s effect on the human immune system and inflammation","volume":"18","author":"Shin SD","year":"2025","unstructured":"Shin SD, Branning R, McGinnis M, et al. Buprenorphine\u2019s effect on the human immune system and inflammation. Clin Transl Sci. 2025;18(3):e70180."},{"issue":"1 Suppl 1","key":"bib16","series-title":"Semin Arthritis Rheum.","first-page":"134","article-title":"Effect of nonsteroidal antiinflammatory drugs on immune function","volume":"13","author":"Goodwin JS","year":"1983","unstructured":"Goodwin JS, Ceuppens JL. Effect of nonsteroidal antiinflammatory drugs on immune function. Semin Arthritis Rheum. 1983;13(1 Suppl 1):134\u2013143."},{"key":"bib17","series-title":"Front Immunol.","first-page":"1441020","article-title":"The relationship between anesthesia, surgery and postoperative immune function in cancer patients: a review","volume":"15","author":"Guo R","year":"2024","unstructured":"Guo R, Yang W-W, Zhong M-L, et al. The relationship between anesthesia, surgery and postoperative immune function in cancer patients: a review. Front Immunol. 2024;15:1441020."},{"issue":"4","key":"bib18","series-title":"Lab Anim.","first-page":"351","article-title":"Analgesics promote welfare and sustain tumour growth in orthotopic 4T1 and B16 mouse cancer models","volume":"52","author":"Lofgren J","year":"2018","unstructured":"Lofgren J, Miller AL, Lee CCS, et al. Analgesics promote welfare and sustain tumour growth in orthotopic 4T1 and B16 mouse cancer models. Lab Anim. 2018;52(4):351\u2013364."},{"key":"bib19","series-title":"Oral Oncol.","first-page":"106363","article-title":"The effect of opioids on the efficacy of immunotherapy in recurrent\/metastatic squamous cell carcinoma of the head and neck","volume":"140","author":"Scheff NN","year":"2023","unstructured":"Scheff NN, Nilsen ML, Li J, et al. The effect of opioids on the efficacy of immunotherapy in recurrent\/metastatic squamous cell carcinoma of the head and neck. Oral Oncol. 2023;140:106363."},{"key":"bib20","series-title":"Eur J Pharmacol.","first-page":"174284","article-title":"Concomitant use of analgesics and immune checkpoint inhibitors in non-small cell lung cancer: a pharmacodynamics perspective","volume":"906","author":"Prasetya RA","year":"2021","unstructured":"Prasetya RA, Metselaar-Albers M, Engels F. Concomitant use of analgesics and immune checkpoint inhibitors in non-small cell lung cancer: a pharmacodynamics perspective. Eur J Pharmacol. 2021;906:174284."},{"issue":"1","key":"bib21","series-title":"Vet Res Commun.","first-page":"1","article-title":"Administration of meloxicam to improve the welfare of mice in research: a systematic review (2000\u20132020)","volume":"46","author":"Antiorio ATFB","year":"2022","unstructured":"Antiorio ATFB, Alem\u00e1n-Laporte J, de Freitas APP, et al. Administration of meloxicam to improve the welfare of mice in research: a systematic review (2000\u20132020). Vet Res Commun. 2022;46(1):1\u20138."},{"issue":"3","key":"bib22","series-title":"Lab Anim Sci.","first-page":"319","article-title":"Body condition scoring: a rapid and accurate method for assessing health status in mice","volume":"49","author":"Ullman-Culler\u00e9 MH","year":"1999","unstructured":"Ullman-Culler\u00e9 MH, Foltz CJ. Body condition scoring: a rapid and accurate method for assessing health status in mice. Lab Anim Sci. 1999;49(3):319\u2013323."},{"issue":"2","key":"bib23","series-title":"Br J Cancer.","first-page":"101","article-title":"The role of mouse tumour models in the discovery and development of anticancer drugs","volume":"121","author":"Ireson CR","year":"2019","unstructured":"Ireson CR, Alavijeh MS, Palmer AM, Fowler ER, Jones HJ. The role of mouse tumour models in the discovery and development of anticancer drugs. Br J Cancer. 2019;121(2):101\u2013108."},{"issue":"9","key":"bib24","series-title":"Biomed Opt Express.","first-page":"3610","article-title":"Chemotherapeutic drug-specific alteration of microvascular blood flow in murine breast cancer as measured by diffuse correlation spectroscopy","volume":"7","author":"Ramirez G","year":"2016","unstructured":"Ramirez G, Proctor AR, Jung KW, et al. Chemotherapeutic drug-specific alteration of microvascular blood flow in murine breast cancer as measured by diffuse correlation spectroscopy. Biomed Opt Express. 2016;7(9):3610\u20133630."},{"issue":"1","key":"bib25","series-title":"Sci Rep.","first-page":"6704","article-title":"2-Dodecyl-6-methoxycyclo-hexa-2,5-diene-1,4-dione inhibits the growth and metastasis of breast carcinoma in mice","volume":"7","author":"Chen C","year":"2017","unstructured":"Chen C, Nong Z, Xie Q, et al. 2-Dodecyl-6-methoxycyclo-hexa-2,5-diene-1,4-dione inhibits the growth and metastasis of breast carcinoma in mice. Sci Rep. 2017;7(1):6704."},{"issue":"1","key":"bib26","series-title":"J Pharmacokinet Pharmacodyn.","first-page":"105","article-title":"Disease progression model of 4T1 metastatic breast cancer","volume":"47","author":"Yang L","year":"2020","unstructured":"Yang L, Yong L, Zhu X, et al. Disease progression model of 4T1 metastatic breast cancer. J Pharmacokinet Pharmacodyn. 2020;47(1):105\u2013116."},{"key":"bib27","series-title":"BMC Cancer.","first-page":"228","article-title":"Imagable 4T1 model for the study of late stage breast cancer","volume":"8","author":"Tao K","year":"2008","unstructured":"Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer. 2008;8:228."},{"issue":"164","key":"bib28","series-title":"J Vis Exp.","article-title":"Using computer-based image analysis to improve quantification of lung metastasis in the 4T1 breast cancer model","volume":"e61805","author":"Nagai-Singer MA","year":"2020","unstructured":"Nagai-Singer MA, Hendricks-Wenger A, Brock RM, et al. Using computer-based image analysis to improve quantification of lung metastasis in the 4T1 breast cancer model. J Vis Exp. 2020;(164):e61805."},{"issue":"114","key":"bib29","series-title":"J Vis Exp.","first-page":"54040","article-title":"An orthotopic mouse model of spontaneous breast cancer metastasis","author":"Paschall AV","year":"2016","unstructured":"Paschall AV, Liu K. An orthotopic mouse model of spontaneous breast cancer metastasis. J Vis Exp. 2016;(114):54040."},{"issue":"143","key":"bib30","series-title":"J Vis Exp.","first-page":"e58604","article-title":"Orthotopic injection of breast cancer cells into the mice mammary fat pad","author":"Zhang Y","year":"2019","unstructured":"Zhang Y, Zhang G-L, Cao K-X, Wang X-M. Orthotopic injection of breast cancer cells into the mice mammary fat pad. J Vis Exp. 2019;(143):e58604."},{"key":"bib31","series-title":"AIP Conf Proc.","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1063\/1.3478200","article-title":"High resolution x\u2010ray microangiography of 4T1 tumor in mouse using synchrotron radiation","volume":"1266","author":"Sun J","year":"2010","unstructured":"Sun J, Liu P, Liu X, et al. High resolution x\u2010ray microangiography of 4T1 tumor in mouse using synchrotron radiation. AIP Conf Proc. 2010;1266:62\u201367."},{"issue":"27","key":"bib32","series-title":"Oncotarget.","first-page":"18720","article-title":"Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas","volume":"9","author":"Li X","year":"2018","unstructured":"Li X, Singh K, Luo Z, et al. Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas. Oncotarget. 2018;9(27):18720\u201318733."},{"issue":"1","key":"bib33","series-title":"Commun Biol.","first-page":"1152","article-title":"Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer","volume":"6","author":"Cook DP","year":"2023","unstructured":"Cook DP, Galpin KJC, Rodriguez GM, et al. Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer. Commun Biol. 2023;6(1):1152."},{"issue":"2","key":"bib34","series-title":"Cancer Discov.","first-page":"384","article-title":"Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy","volume":"11","author":"Iyer S","year":"2021","unstructured":"Iyer S, Zhang S, Yucel S, et al. Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy. Cancer Discov. 2021;11(2):384\u2013407."},{"issue":"9","key":"bib35","series-title":"Nat Med.","first-page":"950","article-title":"Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A","volume":"10","author":"Conejo-Garcia JR","year":"2004","unstructured":"Conejo-Garcia JR, Benencia F, Courreges M-C, et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med. 2004;10(9):950\u2013958."},{"key":"bib36","series-title":"J Immunother Cancer.","first-page":"57","article-title":"The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer","volume":"3","author":"Baert T","year":"2015","unstructured":"Baert T, Verschuere T, Van Hoylandt A, Gijsbers R, Vergote I, Coosemans A. The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer. J Immunother Cancer. 2015;3:57."},{"issue":"6","key":"bib37","series-title":"Cancer Res Commun.","first-page":"417","article-title":"The tumor immune profile of murine ovarian cancer models: an essential tool for ovarian cancer immunotherapy research","volume":"2","author":"Rodriguez GM","year":"2022","unstructured":"Rodriguez GM, Galpin KJC, Cook DP, et al. The tumor immune profile of murine ovarian cancer models: an essential tool for ovarian cancer immunotherapy research. Cancer Res Commun. 2022;2(6):417\u2013433."},{"issue":"1","key":"bib38","series-title":"Br J Cancer.","first-page":"9","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford CE","year":"2020","unstructured":"Ford CE, Werner B, Hacker NF, Warton K. The untapped potential of ascites in ovarian cancer research and treatment. Br J Cancer. 2020;123(1):9\u201316."},{"issue":"8","key":"bib39","series-title":"Cancer Discov.","first-page":"1904","article-title":"Tumor-derived lysophosphatidic acid blunts protective type I interferon responses in ovarian cancer","volume":"12","author":"Chae C-S","year":"2022","unstructured":"Chae C-S, Sandoval TA, Hwang S-M, et al. Tumor-derived lysophosphatidic acid blunts protective type I interferon responses in ovarian cancer. Cancer Discov. 2022;12(8):1904\u20131921."},{"key":"bib40","series-title":"Guide for the Care and Use of Laboratory Animals.","year":"2011","unstructured":"Institute for Laboratory Animal Research. Guide for the Care and Use of Laboratory Animals. 8th ed. National Academies Press; 2011."},{"issue":"5","key":"bib41","series-title":"J Am Assoc Lab Anim Sci.","first-page":"584","article-title":"A novel noninvasive method for evaluating experimental lung metastasis in mice","volume":"52","author":"Mendoza A","year":"2013","unstructured":"Mendoza A, Gharpure R, Dennis J, et al. A novel noninvasive method for evaluating experimental lung metastasis in mice. J Am Assoc Lab Anim Sci. 2013;52(5):584\u2013589."},{"issue":"6","key":"bib42","series-title":"Comp Med.","first-page":"446","article-title":"A novel scoring system for humane endpoints in mice with cecal ligation and puncture-induced sepsis","volume":"73","author":"Ferguson LT","year":"2023","unstructured":"Ferguson LT, Rashied AA, Liang Z, et al. A novel scoring system for humane endpoints in mice with cecal ligation and puncture-induced sepsis. Comp Med. 2023;73(6):446\u2013460."},{"key":"bib43","series-title":"BMC Res Notes.","first-page":"233","article-title":"A robust scoring system to evaluate sepsis severity in an animal model","volume":"7","author":"Shrum B","year":"2014","unstructured":"Shrum B, Anantha RV, Xu SX, et al. A robust scoring system to evaluate sepsis severity in an animal model. BMC Res Notes. 2014;7:233."},{"issue":"4","key":"bib44","series-title":"Comp Med.","first-page":"246","article-title":"A clinical scoring system and impact of athymic nude mouse age on Corynebacterium bovis clinical disease","volume":"74","author":"Manuel CA","year":"2024","unstructured":"Manuel CA, Pugazhenthi U, Fink MK, et al. A clinical scoring system and impact of athymic nude mouse age on Corynebacterium bovis clinical disease. Comp Med. 2024;74(4):246\u2013254."},{"issue":"11","key":"bib45","series-title":"Br J Cancer.","first-page":"1555","article-title":"Guidelines for the welfare and use of animals in cancer research","volume":"102","author":"Workman P","year":"2010","unstructured":"Workman P, Aboagye EO, Balkwill F, et al.; Committee of the National Cancer Research Institute. Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010;102(11):1555\u20131577."},{"issue":"11","key":"bib46","series-title":"R Soc Open Sci.","first-page":"221083","article-title":"Waking inactivity as a welfare indicator in laboratory mice: investigating postures, facial expressions and depression-like states","volume":"9","author":"MacLellan A","year":"2022","unstructured":"MacLellan A, Nazal B, Young L, Mason G. Waking inactivity as a welfare indicator in laboratory mice: investigating postures, facial expressions and depression-like states. R Soc Open Sci. 2022;9(11):221083."},{"issue":"3","key":"bib47","series-title":"Animal Model Exp Med.","first-page":"201","article-title":"The animal cachexia score (ACASCO)","volume":"2","author":"Betancourt A","year":"2019","unstructured":"Betancourt A, Busquets S, Ponce M, et al. The animal cachexia score (ACASCO). Animal Model Exp Med. 2019;2(3):201\u2013209."},{"issue":"2","key":"bib48","series-title":"Gastroenterology.","first-page":"489","article-title":"A rodent model of cirrhosis, ascites, and bacterial peritonitis","volume":"100","author":"Runyon BA","year":"1991","unstructured":"Runyon BA, Sugano S, Kanel G, Mellencamp MA. A rodent model of cirrhosis, ascites, and bacterial peritonitis. Gastroenterology. 1991;100(2):489\u2013493."},{"key":"bib49","series-title":"Front Immunol.","first-page":"1189960","article-title":"The effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependent","volume":"14","author":"Lisec B","year":"2023","unstructured":"Lisec B, M B, Ursic Valentinuzzi K, Sersa G, Cemazar M. The effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependent. Front Immunol. 2023;14:1189960."},{"issue":"38","key":"bib50","series-title":"Oncogene.","first-page":"5318","article-title":"Modeling human lung cancer in mice: similarities and shortcomings","volume":"18","author":"Tuveson DA","year":"1999","unstructured":"Tuveson DA, Jacks T. Modeling human lung cancer in mice: similarities and shortcomings. Oncogene. 1999;18(38):5318\u20135324."},{"issue":"1","key":"bib51","series-title":"Evol Med Public Health.","first-page":"170","article-title":"Mouse models of human disease: an evolutionary perspective","volume":"2016","author":"Perlman RL","year":"2016","unstructured":"Perlman RL. Mouse models of human disease: an evolutionary perspective. Evol Med Public Health. 2016;2016(1):170\u2013176."},{"issue":"4","key":"bib52","series-title":"J Nucl Med.","first-page":"501","article-title":"Of mice and humans: are they the same?\u2014Implications in cancer translational research","volume":"51","author":"de Jong M","year":"2010","unstructured":"de Jong M, Maina T. Of mice and humans: are they the same?\u2014Implications in cancer translational research. J Nucl Med. 2010;51(4):501\u2013504."},{"issue":"2","key":"bib53","series-title":"Ultrasound.","first-page":"69","article-title":"Ascites matters","volume":"25","author":"Rudralingam V","year":"2017","unstructured":"Rudralingam V, Footitt C, Layton B. Ascites matters. Ultrasound. 2017;25(2):69\u201379."},{"issue":"5","key":"bib54","series-title":"Hepatology.","first-page":"1104","article-title":"Ascitic fluid analysis in malignancy-related ascites","volume":"8","author":"Runyon BA","year":"1988","unstructured":"Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology. 1988;8(5):1104\u20131109."},{"issue":"3","key":"bib55","series-title":"Cancer.","first-page":"680","article-title":"Paget\u2019s disease of the breast","volume":"26","author":"Ashikari R","year":"1970","unstructured":"Ashikari R, Park K, Huvos AG, Urban JA. Paget\u2019s disease of the breast. Cancer. 1970;26(3):680\u2013685."},{"issue":"4","key":"bib56","series-title":"PLoS One.","first-page":"e95649","article-title":"Pathway-specific engineered mouse allograft models functionally recapitulate human serous epithelial ovarian cancer","volume":"9","author":"Szabova L","year":"2014","unstructured":"Szabova L, Bupp S, Kamal M, et al. Pathway-specific engineered mouse allograft models functionally recapitulate human serous epithelial ovarian cancer. PLoS One. 2014;9(4):e95649."},{"issue":"1","key":"bib57","series-title":"Sci Rep.","first-page":"18102","article-title":"A mouse model of subacute liver failure with ascites induced by step-wise increased doses of (\u2212)-epigallocatechin-3-gallate","volume":"9","author":"Wang X","year":"2019","unstructured":"Wang X, Yang L, Wang J, et al. A mouse model of subacute liver failure with ascites induced by step-wise increased doses of (\u2212)-epigallocatechin-3-gallate. Sci Rep. 2019;9(1):18102."},{"issue":"6","key":"bib58","series-title":"Nat Methods.","first-page":"447","article-title":"Coding of facial expressions of pain in the laboratory mouse","volume":"7","author":"Langford DJ","year":"2010","unstructured":"Langford DJ, Bailey AL, Chanda ML, et al. Coding of facial expressions of pain in the laboratory mouse. Nat Methods. 2010;7(6):447\u2013449."},{"issue":"9","key":"bib59","series-title":"PLoS One.","first-page":"e0136000","article-title":"The mouse grimace scale: a clinically useful tool?","volume":"10","author":"Miller AL","year":"2015","unstructured":"Miller AL, Leach MC. The mouse grimace scale: a clinically useful tool? PLoS One. 2015;10(9):e0136000."},{"issue":"3","key":"bib60","series-title":"Animals (Basel).","first-page":"673","article-title":"Methods used and application of the mouse grimace scale in biomedical research 10 years on: a scoping review","volume":"11","author":"Whittaker AL","year":"2021","unstructured":"Whittaker AL, Liu Y, Barker TH. Methods used and application of the mouse grimace scale in biomedical research 10 years on: a scoping review. Animals (Basel). 2021;11(3):673."},{"issue":"2","key":"bib61","series-title":"Comp Med.","first-page":"95","article-title":"Monitoring the health status of mice with bleomycin-induced lung injury by using body condition scoring","volume":"69","author":"Cowley PM","year":"2019","unstructured":"Cowley PM, Roberts CR, Baker AJ. Monitoring the health status of mice with bleomycin-induced lung injury by using body condition scoring. Comp Med. 2019;69(2):95\u2013102."}],"container-title":["Journal of the American Association for Laboratory Animal Science"],"original-title":[],"link":[{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010024\/aop\/article-10.30802-AALAS-JAALAS-26-027\/article-10.30802-AALAS-JAALAS-26-027.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010024\/aop\/article-10.30802-AALAS-JAALAS-26-027\/article-10.30802-AALAS-JAALAS-26-027.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T01:42:43Z","timestamp":1784425363000},"score":1,"resource":{"primary":{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010024\/aop\/article-10.30802-AALAS-JAALAS-26-027\/article-10.30802-AALAS-JAALAS-26-027.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":61,"URL":"https:\/\/doi.org\/10.30802\/aalas-jaalas-26-027","relation":{},"ISSN":["1559-6109"],"issn-type":[{"value":"1559-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}